0.732
Shattuck Labs Inc stock is traded at $0.732, with a volume of 79,399.
It is down -3.89% in the last 24 hours and down -10.25% over the past month.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
See More
Previous Close:
$0.7616
Open:
$0.76
24h Volume:
79,399
Relative Volume:
0.35
Market Cap:
$35.07M
Revenue:
$2.72M
Net Income/Loss:
$-85.08M
P/E Ratio:
-0.3793
EPS:
-1.93
Net Cash Flow:
$-70.93M
1W Performance:
-13.50%
1M Performance:
-10.25%
6M Performance:
-36.90%
1Y Performance:
-80.58%
Shattuck Labs Inc Stock (STTK) Company Profile
Name
Shattuck Labs Inc
Sector
Industry
Phone
512-900-4690
Address
500 W. 5TH STREET, AUSTIN
Compare STTK with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
STTK
Shattuck Labs Inc
|
0.732 | 36.48M | 2.72M | -85.08M | -70.93M | -1.93 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Shattuck Labs Inc Stock (STTK) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Mar-17-25 | Initiated | Leerink Partners | Outperform |
Oct-02-24 | Downgrade | Citigroup | Buy → Neutral |
Oct-02-24 | Downgrade | Needham | Buy → Hold |
Oct-01-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
Jun-17-24 | Downgrade | BTIG Research | Buy → Neutral |
Aug-31-22 | Initiated | BTIG Research | Buy |
Jun-01-22 | Initiated | Citigroup | Buy |
May-02-22 | Initiated | H.C. Wainwright | Buy |
Apr-14-21 | Initiated | Berenberg | Buy |
Jan-11-21 | Initiated | Evercore ISI | Outperform |
Nov-03-20 | Initiated | Citigroup | Buy |
Nov-03-20 | Initiated | Cowen | Outperform |
Nov-03-20 | Initiated | Needham | Buy |
View All
Shattuck Labs Inc Stock (STTK) Latest News
How sentiment analysis helps forecast Shattuck Labs Inc.Early Entry Planner for Swing Candidates - Newser
Sentiment analysis tools applied to Shattuck Labs Inc.Free Reliable Investment Entry Point Signals - Newser
Momentum divergence signals in Shattuck Labs Inc. chartDaily Technical Chart Pattern Analysis Report - Newser
Nexien Biopharma (OTCMKTS:NXEN) vs. Shattuck Labs (NASDAQ:STTK) Financial Comparison - Defense World
What momentum shifts mean for Shattuck Labs Inc.Trade Safety Matrix for Conservative Traders - Newser
What makes Shattuck Labs Inc. stock attractive to long term investorsAI Short-Term Gain Forecast with Data - Newser
Can Shattuck Labs Inc. recover in the next quarterFree Portfolio Diversification Stock Ideas - Newser
Should I hold or sell Shattuck Labs Inc. stock in 2025Smart Portfolio Alerts That Work - jammulinksnews.com
What makes Shattuck Labs Inc. stock price move sharplyROI Prediction from Long-Term Holding Plans - Newser
Will Shattuck Labs Inc. rebound enough to break evenFree Trend Following Strategy With Stop Loss - Newser
Applying Elliott Wave Theory to Shattuck Labs Inc.Momentum Detection with Entry Optimization - Newser
Analyzing recovery setups for Shattuck Labs Inc. investorsFree Breakout Confirmation With Entry Tracker - Newser
Is Shattuck Labs Inc. stock overvalued or undervaluedAI Powered Review For 2025 - jammulinksnews.com
Shattuck Labs (STTK) Expected to Announce Earnings on Thursday - Defense World
Applying Wyckoff theory to Shattuck Labs Inc. stockFree Chart Driven High Reward Trading Setup - Newser
Will breakout in Shattuck Labs Inc. lead to full recoveryVolume Based Swing Signal Prediction Map - Newser
Competitive Positioning of Shattuck Labs Inc.: Is It Leading or LaggingWeekly Stock Opportunity Radar Scanner Activated - metal.it
Shattuck Labs Inc. Building a Base Near SupportSwing Trade Entry With Volume Triggers Released - metal.it
Shattuck Labs Inc.’s volatility index tracking explainedTrend Following Ideas with Volume Confirmation - Newser
How does STTK manage its rising costs? - AInvest
What are the latest earnings results for Shattuck Labs Inc.Unmatched profit growth - jammulinksnews.com
Shattuck Labs Inc. Recovery Likely Here’s What Data ShowsWatchlist for Smart Swing Trading Updated - metal.it
Is it the right time to buy Shattuck Labs Inc. stockConsistent triple returns - jammulinksnews.com
How volatile is Shattuck Labs Inc. stock compared to the marketExpert Picks Watchlist For 2025 - jammulinksnews.com
Does Shattuck Labs Inc. stock perform well during market downturnsFree Wealth Planning Blueprint - jammulinksnews.com
What is Shattuck Labs Inc. company’s growth strategyAchieve rapid capital gains with smart investing - jammulinksnews.com
Is Shattuck Labs Inc. a good long term investmentDynamic investment opportunities - PrintWeekIndia
What drives Shattuck Labs Inc. stock priceUnmatched profit potential - PrintWeekIndia
Shattuck Labs Inc. Stock Analysis and ForecastUnstoppable profit momentum - Autocar Professional
Does Shattuck Labs Inc. stock pay reliable dividendsSuperior investment outcomes - jammulinksnews.com
Is Shattuck Labs Inc. stock overhyped or has real potentialBreakneck growth rates - jammulinksnews.com
Shattuck Labs Inc Stock (STTK) Financials Data
Revenue
Net Income
Cash Flow
EPS
Shattuck Labs Inc Stock (STTK) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Redmile Group, LLC | Director |
Dec 04 '24 |
Sale |
1.25 |
133,371 |
166,714 |
5,406,353 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):